How many stocks are there of Cryosite?
The current number of stocks of Cryosite is 48.81 M undefined.
Cryosite Stocks 2025
Cryosite Stocks
48.81 M
Ticker
CTE.AX
ISIN
AU000000CTE1
WKN
621943
In 2025, Cryosite had 48.81 M outstanding stocks, a 0% change from the 48.81 M stocks in the previous year.
The Cryosite Stocks history
| YEAR | NUMBER OF STOCKS (undefined AUD) |
|---|---|
| 2024 | 48.81 |
| 2023 | 48.81 |
| 2022 | 48.81 |
| 2021 | 46.86 |
| 2020 | 48.81 |
| 2019 | 46.86 |
| 2018 | 46.86 |
| 2017 | 46.86 |
| 2016 | 46.98 |
| 2015 | 47.16 |
| 2014 | 47.16 |
| 2013 | 46.64 |
| 2012 | 47.16 |
| 2011 | 47.16 |
| 2010 | 46.64 |
| 2009 | 46.64 |
| 2008 | 48.01 |
| 2007 | 47.92 |
| 2006 | 46.52 |
| 2005 | 45.01 |
Cryosite shares outstanding AU000000CTE1 · 621943
The number of shares was Cryosite in 2024 — This indicates how many shares 48.81 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Cryosite earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Cryosite's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Cryosite’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Cryosite's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2005 | 45.01 M Aktien |
| 2006 | 46.52 M Aktien |
| 2007 | 47.92 M Aktien |
| 2008 | 48.01 M Aktien |
| 2009 | 46.64 M Aktien |
| 2010 | 46.64 M Aktien |
| 2011 | 47.16 M Aktien |
| 2012 | 47.16 M Aktien |
| 2013 | 46.64 M Aktien |
| 2014 | 47.16 M Aktien |
| 2015 | 47.16 M Aktien |
| 2016 | 46.98 M Aktien |
| 2017 | 46.86 M Aktien |
| 2018 | 46.86 M Aktien |
| 2019 | 46.86 M Aktien |
| 2020 | 48.81 M Aktien |
| 2021 | 46.86 M Aktien |
| 2022 | 48.81 M Aktien |
| 2023 | 48.81 M Aktien |
| 2024 | 48.81 M Aktien |
Cryosite Aktienanalyse
What does Cryosite do?
Cryosite Ltd was founded in Australia in 1999 and has since become a leading provider of services in the field of biological sample storage. The company specializes in the storage of blood, bone marrow, tissue, and other biological samples. Based in Sydney, Cryosite Ltd operates branches throughout Australia and is increasingly expanding into international business. Cryosite Ltd's business model is based on providing secure and reliable storage solutions for biological samples. This includes the collection, processing, and storage of biological samples, as well as their transportation and traceability. Cryosite Ltd offers its customers a comprehensive range of services to facilitate the storage and shipment of biological samples. This includes the development of customized archiving solutions tailored to individual needs. The company's various divisions include archiving solutions, clinical trials, stem cell therapy, biobanking, and blood banks. Cryosite Ltd's archiving solutions involve the setup, maintenance, and monitoring of biological samples in engraved tubes and boxes. The company offers a variety of cryopreservation systems to ensure that samples are stored under optimal conditions and can be retrieved within a specified timeframe. Additionally, the company also provides digital archiving solutions that enable efficient management and retrieval of stored data. Cryosite Ltd is also involved in clinical trials by assisting companies in conducting clinical studies. The company provides the necessary logistics and sample management to ensure that samples are properly processed, stored, and returned. It also provides comprehensive documentation to ensure the highest compliance standards. In the field of stem cell therapy, Cryosite Ltd offers a wide range of services that enable companies and researchers to store and process stem cells under optimal conditions. The company specializes in providing a wide range of application-oriented solutions and is a leader in the industry in supporting customers in the use of these technologies to enhance diagnostic and therapeutic discoveries. In the field of biobanking, Cryosite Ltd offers a comprehensive range of services to research institutes and organizations. Biobanking services include the setup, storage, monitoring, and tracking of biological samples for future research purposes. The company also offers services for the biobanking of clinical samples for disease diagnosis and evaluation. The company also operates blood banks that focus on blood donation and storage of blood products for efficient availability to patients. It offers a wide range of blood bank products and services to ensure effective blood supply for patients. Cryosite Ltd is committed to providing its customers with the highest standards in the storage and handling of blood products. In summary, Cryosite Ltd is a leading provider of storage and processing services for biological samples. The company has a long history of providing solutions for a wide range of applications in medical research and the medical industry. It strives to meet the highest standards and ensure that all samples are processed and stored efficiently and safely. Cryosite Ltd stays up to date with the latest technology and advanced processes to handle samples with maximum efficiency and quality. Cryosite ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Cryosite's Shares Outstanding
Cryosite's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Cryosite’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Cryosite’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Cryosite’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Cryosite stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Cryosite are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Cryosite evolved in recent years?
The number of shares of Cryosite has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Cryosite as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Cryosite?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Cryosite pay?
Over the past 12 months, Cryosite paid a dividend of 0.07 AUD . This corresponds to a dividend yield of about 10 %. For the coming 12 months, Cryosite is expected to pay a dividend of 0.07 AUD.
What is the dividend yield of Cryosite?
The current dividend yield of Cryosite is 10 %.
When does Cryosite pay dividends?
Cryosite pays a quarterly dividend. This is distributed in the months of October, October, March, October.
How secure is the dividend of Cryosite?
Cryosite paid dividends every year for the past 3 years.
What is the dividend of Cryosite?
For the upcoming 12 months, dividends amounting to 0.07 AUD are expected. This corresponds to a dividend yield of 10 %.
In which sector is Cryosite located?
Cryosite is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cryosite kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cryosite from 10/10/2024 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Cryosite pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cryosite in the year 2024?
In the year 2024, Cryosite distributed 0.015 AUD as dividends.
In which currency does Cryosite pay out the dividend?
The dividends of Cryosite are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cryosite
Our stock analysis for Cryosite Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cryosite Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
